BIO News
Bio-Rad Laboratories, Inc.
$362.43
-$1.30(-0.36%)
53
Overall
70
Value
45
Tech
44
Quality
Market Cap
$9.69B
Volume
297.39K
52W Range
$236.73 - $396.23
Target Price
$364.33
BIO news: the latest Bio-Rad Laboratories, Inc. headlines, press releases and market updates, newest first.
Latest BIO News
- Piper Sandler Remains a Buy on Orchestra BioMed Holdings (OBIO)TipRanks Auto-Generated Intelligence Newsdesk · Oct 15, 2026
- BridgeBio Pharma (BBIO) Receives a New Rating from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Doğanlar Yatırım Holding Raises Stake in Biotrend to 46.65%TipRanks Turkey Auto-Generated Newsdesk · Oct 14, 2026
- Wedbush Remains a Buy on Zenas BioPharma, Inc. (ZBIO)TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
- iBio Highlights IBIO-610 Obesity Antibody Preclinical ResultsTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- Analysts Are Bullish on Top Healthcare Stocks: Zenas BioPharma, Inc. (ZBIO), Ocular Therapeutix (OCUL)TipRanks Newsroom · Oct 13, 2026
- Biosynex exits safeguard proceedings after court approves restructuring planTipRanks European Auto-Generated Newsdesk · Oct 12, 2026
- JCR Eurasia Downgrades Biotrend’s National Credit Rating on Weaker 2026 MetricsTipRanks Turkey Auto-Generated Newsdesk · Oct 12, 2026
- MKK Filing Reveals Major Shifts in Turkish Equity Ownership, Including MMC Sanayi ve Ticari Yatirimlar A.S.TipRanks Turkey Auto-Generated Newsdesk · Oct 12, 2026
- BioAge Labs, Inc. (BIOA) Has a New Rating from UBSTipRanks Auto-Generated Intelligence Newsdesk · Oct 11, 2026
- RBC Capital Reaffirms Their Buy Rating on BridgeBio Pharma (BBIO)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Wall Street Analysts Are Bullish on Top Healthcare PicksTipRanks Newsroom · Oct 7, 2026
- BridgeBio Pharma (BBIO) Receives a Buy from BarclaysTipRanks Auto-Generated Intelligence Newsdesk · Oct 7, 2026
- Crescent Biopharma (CBIO) Gets a Buy from Stifel NicolausTipRanks Auto-Generated Intelligence Newsdesk · Oct 6, 2026
- Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)TipRanks Newsroom · Oct 5, 2026
- Biome Australia appoints Moore Australia Audit as new external auditorTipRanks Australian Auto-Generated Newsdesk · Oct 5, 2026
- BioAge Labs initiates Phase 2 trial for BGE-102TipRanks Auto-Generated Newsdesk · Oct 2, 2026
- Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO) and Biogen (BIIB)TipRanks Newsroom · Oct 2, 2026
- Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT) and Jade Biosciences (JBIO)TipRanks Newsroom · Oct 1, 2026
- Orchestra BioMed Completes Enrollment in BACKBEAT AVIM TrialTipRanks Auto-Generated Newsdesk · Oct 1, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIO | $362.43 | -0.4% | 297.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bio-Rad Laboratories, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW